Natera to Report its Third Quarter Results on November 6, 2025
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Earnings Conference Call Information |
||
Event: |
Natera’s Third Quarter 2025 Financial Results |
|
Date: |
November 6, 2025 |
|
Time: |
4:30 p.m. ET |
|
Live Dial-In: |
1-888-770-7321 (Domestic) |
|
|
1-929-201-7107 (International) |
|
Conference ID: |
7684785 |
|
Webcast: |
||
A webcast replay will be available at investor.natera.com.
About Natera
Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 325 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in
View source version on businesswire.com: https://www.businesswire.com/news/home/20251030336447/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc., investor@natera.com
Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com
Source: Natera, Inc.